July 31, 2023 Comments Off on New patent expiration for Astrazeneca Ab drug KOMBIGLYZE XR Posted in: Uncategorized
Annual Drug Patent Expirations for KOMBIGLYZE+XR Kombiglyze Xr is a drug marketed by Astrazeneca Ab and is included in one NDA. It is available from one supplier. There are three…
The post New patent expiration for Astrazeneca Ab drug KOMBIGLYZE XR app…
July 31, 2023 Comments Off on New tentative approval for Optimus Pharma drug obeticholic acid Posted in: Tentative Approval Obeticholic acid is the generic ingredient in one branded drug marketed by Intercept Pharms Inc and is included in one NDA. There are ten patents protecting this compound. Drug patent…
The post New tentative approval for Optimus Pharma drug obeticholic…
